Whitehawk Therapeutics Inc

NASDAQ:WHWK

Biotechnology

Healthcare
$3.13 +1.42%

+$0.06 today

Market cap
$184.70M
Beta
0.77
P/E (TTM)
-2.6
EPS (TTM)
-$1.67
52W Low $1.57High $5.50

Volume 0.28M

Average 0.31M

WHWK Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Whitehawk Therapeutics IncNASDAQ: WHWK

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows in line with its trailing trend

Q1 FY2026 weighted avg shares of 69.24M shares rose 155.6% year over year, ahead of the +154.8% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at +40.1% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +155.6% holds above the trailing-twelve-month pace of +154.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
69.24M+0.0% QoQ
Last fiscal yearDec 2025
61.89M+129.0% YoY
LTMMar 2026
68.95M+154.8% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+155.6%——
1 year+129.0%——
3-year CAGR+40.1%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
61.89M USD
Year-over-year change
+129.0%
4-year CAGR
+62.5%

Weighted Avg Shares vs competitors

How WHWK compares with its peers on the latest reported figures

  • WHWK's LTM Mar 2026 weighted avg shares of 68.95M shares is the 5th highest of the 9 companies compared; the peer median is 67.38M shares.
  • Its year-over-year change of +154.8% is the highest of 9, against a peer median of +12.4%.
  • Over three fiscal years its annual growth of +40.1% compares with a peer median of +15.8%.
WHWK Competitors Peer median
Weighted Avg Shares for WHWK and competitors
Company Period LTM YoY 3-year CAGR
ONCYOncolytics Biotech Inc.LTM Mar 2026100.12M +27.6%+18.2%
CNTXContext Therapeutics Inc.LTM Mar 202694.36M +30.6%+81.3%
OVIDOvid Therapeutics Inc.LTM Mar 202674.41M +4.8%+1.5%
ZNTLZentalis Pharmaceuticals, Inc.LTM Mar 202671.52M +0.4%+10.8%
WHWKWhitehawk Therapeutics IncLTM Mar 202668.95M +154.8%+40.1%
MGNXMacroGenics, Inc.LTM Mar 202663.24M +0.8%+0.9%
PLRXPliant Therapeutics, Inc.LTM Mar 202661.49M +1.3%+13.5%
IMMXImmix Biopharma, Inc.LTM Mar 202634.62M +19.9%+33.4%
CLNNClene Inc.LTM Mar 202610.33M +43.7%+44.6%
Peer median (excluding WHWK) 67.38M+12.4%+15.8%

Competitors are the stored peer set for WHWK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.12M15.22M24.35M25.98M7.15M
Cost of Revenue19.67M34M51.74M54.05M760K
Gross Profit(18.55M)(18.78M)(27.38M)(28.07M)6.39M
Gross Margin-1656.3%-123.4%-112.4%-108.0%89.4%
Research & Development19.67M32.66M48.93M51.03M90.96M
Selling, General & Admin18.51M40.18M44.55M36.75M29.82M
Operating Expenses92.67M43.9M44.55M39.39M120.79M
Depreciation & Amortization105K159K169K193K79K
EBITDA(36.96M)(58.8M)(65.37M)(64.63M)(20.52M)
EBITDA Margin-3299.6%-386.4%-268.4%-248.7%-287.2%
Operating Income(111.22M)(62.68M)(71.93M)(67.46M)(114.4M)
Operating Margin-9930.1%-411.9%-295.4%-259.6%-1601.1%
Interest Income13K2.4M6.4M3.93M6.23M
Interest Expense665K230K231K154K0
Other Income / Expenses1.13M2.17M6.17M3.77M93.8M
Income Before Tax(110.09M)(60.51M)(65.77M)(63.69M)(20.6M)
Pre-Tax Margin-9829.3%-397.7%-270.0%-245.1%-288.3%
Income Tax Expense2K0000
Net Income(110.09M)(60.51M)(65.77M)(63.69M)(20.6M)
Net Margin-9829.5%-397.7%-270.0%-245.1%-288.3%
EPS (Basic)(12.41)(2.69)(2.44)(2.36)(0.33)
EPS (Diluted)(12.41)(2.69)(2.44)(2.36)(0.33)
Weighted Avg Shares8.87M22.51M26.92M27.03M61.89M
Weighted Avg Shares (Diluted)8.92M22.51M26.92M27.03M61.89M

Whitehawk Therapeutics Inc

NASDAQ:WHWK

Intrinsic Alpha fair value

Locked

Current Price

$3.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.